Sharon D. Ricardo

Clayton, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

The AT2 receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

The AT2 receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Journal: Expert opinion on therapeutic targets

Published: June 15, 2026

Corrigendum to "Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice," [Biomed. Pharmacother. 158 (2023) 114069].

Corrigendum to "Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice," [Biomed. Pharmacother. 158 (2023) 114069].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 21, 2026

Sex-dependent differences in the progression of renal injury and fibrosis following ischemic acute kidney injury.

Sex-dependent differences in the progression of renal injury and fibrosis following ischemic acute kidney injury.

Journal: Clinical science (London, England : 1979)

Published: October 26, 2025

Sex-dependent differences in the progression of renal injury and fibrosis following ischemic acute kidney injury.

Sex-dependent differences in the progression of renal injury and fibrosis following ischemic acute kidney injury.

Journal: Clinical science (London, England : 1979)

Published: October 26, 2025

Single-Cell Fluorescence Imaging Reveals Heterogeneity in Senescence Biomarkers and Identifies Rapamycin-Responsive Sub-Populations.

Single-Cell Fluorescence Imaging Reveals Heterogeneity in Senescence Biomarkers and Identifies Rapamycin-Responsive Sub-Populations.

Journal: Aging cell

Published: November 26, 2024

Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers.

Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers.

Journal: American journal of physiology. Renal physiology

Published: September 19, 2024

The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.

The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.

Journal: Stem cell research & therapy

Published: August 06, 2024

Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology.

Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology.

Journal: Kidney international reports

Published: July 17, 2024

Elucidating the cell penetrating properties of self-assembling β-peptides.

Elucidating the cell penetrating properties of self-assembling β-peptides.

Journal: Nanoscale

Published: September 04, 2023

The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening.

The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening.

Journal: Cell metabolism

Published: August 21, 2023

GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals.

GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals.

Journal: American journal of human genetics

Published: March 30, 2023

The protective effects of a novel AT2 receptor agonist, β-Pro7Ang III in ischemia-reperfusion kidney injury.

The protective effects of a novel AT2 receptor agonist, β-Pro7Ang III in ischemia-reperfusion kidney injury.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 29, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026